BeStock  
Stocks › Biotechnology › SGP

SpyGlass Pharma SGP

US equityMarket cap rank #3144Biotechnology
$30.43 −$0.35 (-1.14%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $30.43 0.00%
Open$30.12
Prev close$30.78
Day range$29.07 – $31.73
Volume108.9K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.4%+0.69 pts vs. prior quarter
Institutions holding85+15 vs. prior quarter
Insider trades (recent)21 buys / 0 sellsNet buying
Short interest3.47% of floatDays to cover 12.1 · as of 30 Oct 2026
Short-sale volume share22.3%5-day average of daily volume

Short-sale volume as % of daily volume

5%18%32%46%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$386.8K (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

+$432.2KSuper−$45.3KBig−$22.3KMid+$113.3KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 70.0% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.23.97%
  • New Enterprise Associates, Inc.22.09%
  • Vensana Capital Management, LLC9.90%
  • Sands Capital Alternatives, LLC7.47%
  • Gilde Healthcare Partners BV6.54%
  • Samsara BioCapital LLC6.31%
  • Malik Kahook2.61%
  • BlackRock2.13%

By investor type

  • VC/PE Fund76.28%
  • Mutual Fund13.04%
  • Hedge Fund5.73%
  • Individual/Insider4.27%
  • Public Company0.23%
  • Insurance Company0.04%
  • Government Pension Fund0.03%
  • Private Company0.01%

Reported short interest has risen from 3.40% to 3.47% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +366,662 2.9%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +226,398 2.0%
State Street Global Advisors Mutual Fund 2026/Q3 +59,310 0.5%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +38,058 0.1%
TD Asset Management Mutual Fund 2026/Q3 +29,400 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +21,905 0.1%
Morgan Stanley Public Company 2026/Q3 +21,393 0.1%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +21,393 0.1%
abrdn plc Mutual Fund 2026/Q3 +13,426 1.5%
ALPS Advisors, Inc. Mutual Fund 2026/Q3 +10,370 0.1%
JPMorgan Chase & Co. Public Company 2026/Q3 +6,867 0.1%
Invesco Ltd. Mutual Fund 2026/Q3 +5,568 0.0%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +14,649 0.0%
BlackRock Mutual Fund 2026/Q3 +566,973 2.1%
abrdn plc Mutual Fund 2026/Q3 +272,622 1.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Feb 2026 New Enterprise Associates, Inc. Private Acquisition +937,500 $16.00 7,392,301
8 Feb 2026 New Enterprise Associates, Inc. Derivative Exercise and Retained +6,454,801 – 7,392,301
8 Feb 2026 RA Capital Management, L.P. Private Acquisition +3,690,000 $16.00 8,021,117
8 Feb 2026 RA Capital Management, L.P. Derivative Exercise and Retained +4,331,117 – 8,021,117
8 Feb 2026 Gilde Healthcare Partners BV Private Acquisition +312,500 $16.00 2,187,513
8 Feb 2026 Gilde Healthcare Partners BV Derivative Exercise and Retained +1,875,013 – 2,187,513
8 Feb 2026 Bilal Khan Independent Director Private Acquisition +135,000 $16.00 276,877
4 Feb 2026 Scott Sandell Initial Statement of Beneficial +0 – 737,962
4 Feb 2026 Geoffrey Pardo Independent Director Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Mohamad Makhzoumi Initial Statement of Beneficial +0 – 737,962
4 Feb 2026 Elizabeth O'Farrell Other Derivative Acquisition +13,700 $16.00 13,700
4 Feb 2026 Elizabeth O'Farrell Initial Statement of Beneficial +0 – 65,976
4 Feb 2026 RA Capital Management, L.P. Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 RA Capital Management, L.P. Initial Statement of Beneficial +0 – 494,647
4 Feb 2026 Jean-Frederic Viret Chief Financial Officer Other Derivative Acquisition +17,500 $16.00 17,500
4 Feb 2026 Jean-Frederic Viret Chief Financial Officer Initial Statement of Beneficial +0 – 263,907
4 Feb 2026 Kirk Nielsen Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Michael Dybbs Independent Director Other Derivative Acquisition +27,400 $16.00 27,400
4 Feb 2026 Malik Kahook Co-Founder, President, Chief Medical Officer & Executive Chairman Other Derivative Acquisition +105,000 $16.00 105,000
4 Feb 2026 Malik Kahook Co-Founder, President, Chief Medical Officer & Executive Chairman Initial Statement of Beneficial +0 – 434,738

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 1,160,601 3.5% 12.1
15 Oct 2026 1,224,357 3.7% 15.7
30 Sep 2026 1,253,724 3.7% 7.1
15 Sep 2026 1,229,711 3.7% 11.6
31 Aug 2026 1,096,948 3.3% 15.8
14 Aug 2026 1,136,810 3.4% 15.2

Discussion

No comments yet — be the first to weigh in on SGP.

Sign in to join the discussion.

Scroll to Top